(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FOUNTAINRX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

FOUNTAINRX

ST13

US500000088026755

Class

35

Filing

88026755

Registration

6991877

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

02/28/2023

Trademark type

Word

Nice classes

35

Filing date

07/05/2018

Registration date

02/28/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/28/2023

Last transaction

02/28/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2022-05-00

First use in commerce

2022-05-00

Drawing code

4

Owner type

16

Owner location

Morristown, TN, US

Examiner

SIRIGNANO, EMMA MARIE

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Fountain Plaza Pharmacy, LLC

Representatives

Jacob G. Horton PITTS & LAKE, P.C.

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Retail pharmacy services

Publications

History of USPTO decisions and trademark events.

29 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/28/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

02/28/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/26/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/25/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/23/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/05/2022

IUAF

USE AMENDMENT FILED

11/16/2022

EISU

TEAS STATEMENT OF USE RECEIVED

11/16/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/18/2022

EX1G

SOU EXTENSION 1 GRANTED

05/16/2022

EXT1

SOU EXTENSION 1 FILED

05/16/2022

EEXT

SOU TEAS EXTENSION RECEIVED

05/16/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/16/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/21/2021

PUBO

PUBLISHED FOR OPPOSITION

09/21/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/01/2021

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

08/27/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/19/2021

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

12/19/2020

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

06/19/2020

ALIE

ASSIGNED TO LIE

06/11/2020

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

11/18/2019

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

04/30/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

10/25/2018

GNSL

LETTER OF SUSPENSION E-MAILED

10/25/2018

CNSL

SUSPENSION LETTER WRITTEN

10/25/2018

DOCK

ASSIGNED TO EXAMINER

10/24/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/11/2018

NWAP

NEW APPLICATION ENTERED

07/09/2018

Continuous trademark protection

Get notified about every new filing that threatens FOUNTAINRX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.